Dataset Information

Process evaluation of co-designed interventions to improve communication of positive newborn bloodspot screening results.

ABSTRACT:

Objective

To implement and evaluate co-designed interventions to improve communication of positive newborn bloodspot screening results and make recommendations for future research and practice.

Design

A process evaluation underpinned by Normalisation Process Theory.

Setting

Three National Health Service provider organisations in England.

Participants

Twenty-four healthcare professionals (7 newborn screening laboratory staff and 24 clinicians) and 18 parents were interviewed.

Interventions

Three co-designed interventions were implemented in practice: standardised laboratory proformas, communication checklists and an email/letter template.

Primary outcome measures

Acceptability and feasibility of the co-designed interventions.

Results

Auditing the implementation of these interventions revealed between 58%-76% of the items on the laboratory proforma and 43%-80% of items on the communication checklists were completed. Interviews with healthcare professionals who had used the interventions in practice provided positive feedback in relation to the purpose of the interventions and the ease of completion both of which were viewed as enhancing communication of positive newborn bloodspot screening results. Interviews with parents highlighted the perceived benefit of the co-designed interventions in terms of consistency, pacing and tailoring of information as well as providing reliable information to families following communication of the positive newborn bloodspot screening result. The process evaluation illuminated organisational and contextual barriers during implementation of the co-designed interventions in practice.

Conclusion

Variations in communication practices for positive newborn bloodspot screening results continue to exist. The co-designed interventions could help to standardise communication of positive newborn screening results from laboratories to clinicians and from clinicians to parents which in turn could improve parents' experience of receiving a positive newborn bloodspot screening result. Implementation highlighted some organisational and contextual barriers to effective adoption of the co-designed interventions in practice.

Trial registration number

ISRCTN15330120.

SUBMITTER: Chudleigh J

PROVIDER: S-EPMC8404436 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:Background and study aims Colorectal cancer is one of the most commonly occurring types of cancer worldwide. It negatively impacts people’s quality of life and is costly for both health services and patients. If colorectal cancer is found early, it’s easier to treat and there’s a better chance of recovery. Screening is a very effective way of detecting the disease in its early stages. However, of those who are invited to take part in screening in Ireland, only 41.9% take part. Research from around the world has shown that there may be many reasons for people not taking up screening (e.g. fear or negative attitudes to screening, lack of time or ability to access screening, poor knowledge about the benefits of screening or healthcare professionals not advising patients to take part in screening). This study aims to improve colorectal cancer screening uptake and improve patient outcomes. This will be done by developing a new screening invitation letter and a new information leaflet to encourage people to participate in colorectal cancer screening. Who can participate? People aged 60 years old who are invited to participate in colorectal cancer screening for the first time and randomly allocated by the National Screening Service to be invited to participate in the study What does the study involve? Participants are invited to complete an online consent and a questionnaire accessible online. They can complete this questionnaire whenever suits them, within 3 months from the receipt of the letter. This takes about 15 minutes. The data collected in the questionnaire will be treated anonymously. At the end of the questionnaire, participants will be offered the possibility to provide their contact details on another form if they wish to participate in an interview (about 30-60 minutes depending on their availability) to give more feedback about the BowelScreen programme and the materials they received. Their contact details will not be related to their questionnaire responses. Completing the questionnaire does not require them to participate in an interview.

Project description:Newborn bloodspot screening (NBS) involves testing a small sample of blood taken from the heel of the newborn for a number of serious and life-limiting conditions. In Canada, newborn screening programmes fall under provincial and territorial jurisdiction with no federal coordination. To date, we know very little about the underlying beliefs around different consent practices or how terminology is interpreted by different individuals. Differences in attitudes may have important healthcare consequences. This study will provide empirical data comparing stakeholder opinions on their understanding of consent-related terminology, the perceived applicability of different consent approaches to newborn screening, and the requirements of these different approaches.Parents, healthcare professionals and policymakers will be recruited in the provinces of Ontario and Newfoundland and Labrador. Parents will be identified through records held by each provincial screening programme. Healthcare professionals will be purposively sampled on the basis of engagement with newborn screening. Within each province we will identify policymakers who have policy analysis or advisory responsibilities relating to NBS. Data collection will be by qualitative interviews. We will conduct 20 interviews with parents of young children, 10 interviews with key healthcare professionals across the range of appropriate specialties and 10 with policymakers at each site (40 per site, total, N=80). The examination of the transcripts will follow a thematic analysis approach. Recruitment started in June 2014 and is expected to be complete by June 2015.This study received ethics approval from the Ottawa Health Science Network Research Ethics Board, the Children's Hospital of Eastern Ontario Research Ethics Board (both Ontario), and the Health Research Ethics Authority (Newfoundland and Labrador).These will be reported in peer-reviewed publications and conference presentations. The results will have specific application to the development of parent education materials for newborn screening.